Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8324260 Methods of treating pediatric patients using dexmedetomidine

Patent 8324260 was granted and assigned to Hospira on December, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Hospira

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83242600

Patent Inventor Names

Marcelo Garcia da Rocha0

Dennis James Stalker0

Edward Koo0

Wayne Wisemandle0

Date of Patent

December 4, 2012

Patent Application Number

134714030

Date Filed

May 14, 2012

Patent Citations Received

‌

US Patent 12090140 Non-sedating dexmedetomidine treatment regimens

‌

US Patent 11998529 Non-sedating dexmedetomidine treatment regimens

‌

US Patent 11783046 Anomaly and causation detection in computing environments

‌

US Patent 11839604 Use of sublingual dexmedetomidine for the treatment of agitation

‌

US Patent 11786508 Use of sublingual dexmedetomidine for the treatment of agitation

‌

US Patent 11890272 Non-sedating dexmedetomidine treatment regimens

‌

US Patent 11931340 Use of sublingual dexmedetomidine for the treatment of agitation

‌

US Patent 11998528 Non-sedating dexmedetomidine treatment regimens

...

Patent Primary Examiner

‌

Sreeni Padmanabhan

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8324260 Methods of treating pediatric patients using dexmedetomidine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API